Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable tech could revolutionize tremor tracking at home

NCT ID NCT07787299

Knowledge-focused Sponsor: Heriot-Watt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Sep 01, 2026 · Updated 3 times

Summary

This study is testing whether wearable sensors can reliably measure tremor and arm movement in people with Parkinson's disease or Essential Tremor. Participants will wear the sensors during a clinic visit and possibly at home for up to three weeks. The goal is to see if these devices can collect useful data that might one day help monitor symptoms continuously. The study does not change any medication or treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wearable inertial sensor monitoring (PD-WATCH and comparator sensors)
What this could lead to
If successful, this could lead to better ways to monitor tremor and movement continuously at home, potentially improving care and clinical trials for Parkinson's and Essential Tremor.
What could go wrong
This is an early observational study with a small number of participants. The sensors may not be comfortable or may not capture data accurately enough for real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with a clinical diagnosis of idiopathic Parkinson's disease or essential tremor receiving care through NHS Lothian services. Potential participants will be identified through relevant NHS clinical pathways.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 18 years or older. 2. Clinical diagnosis of idiopathic Parkinson's disease (Hoehn and Yahr stage I-III) or essential tremor. 3. Motor or tremor symptoms confirmed on clinical assessment. 4. Able to walk at least 4 metres independently, with or without a walking aid. 5. Able to provide written informed consent and comply with study procedures. 6. Willing and able to wear the study sensors in clinic and, where applicable, at home. 7. Able to understand study information and complete study materials in English. Exclusion Criteria: 1. A recent major cardiovascular or cerebrovascular event, or another unstable condition that would make participation unsafe. 2. An uncontrolled psychiatric disorder, ongoing substance misuse, active systemic cancer treatment, or another serious illness likely to interfere with participation. 3. Pregnancy at enrolment. 4. Active skin disease or known allergy to adhesive plaster at anticipated sensor sites. 5. Dementia with Lewy Bodies, atypical, vascular, or drug-induced parkinsonism. 6. Previous invasive neuromodulation or neurosurgery for a movement disorder, including deep brain stimulation. 7. Current or recent participation in another interventional study that could affect safety or study outcomes. 8. In the investigator's opinion, unable to complete the study procedures safely.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Essential tremor are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential tremor Parkinson disease Tremor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease (disorder)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinical Research Facility, Western General Hospital, NHS Lothian

    Edinburgh, Edinburgh, EH4 2XU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.